Related Experiment Video
Updated: Mar 26, 2026

Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4
Published on: December 31, 2013
Tryptamine-Based Derivatives as Transient Receptor Potential Melastatin Type 8 (TRPM8) Channel Modulators
Alessia Bertamino1, Carmine Ostacolo2, Paolo Ambrosino3
1Department of Pharmacy, University of Salerno , Via G. Paolo II 132, 84084, Fisciano, Salerno, Italy.
Researchers explored N-substituted tryptamines for modulating the transient receptor potential melastatin type 8 (TRPM8) channel. They discovered an activator (compound 21) and an inhibitor (compound 12), offering new therapeutic strategies for TRPM8-related conditions.
Area of Science:
- Pharmacology
- Neuroscience
- Molecular Biology
Background:
- The transient receptor potential melastatin type 8 (TRPM8) channel is a target for pain and disease treatment.
- Understanding TRPM8 modulation is crucial for developing novel therapeutics.
Purpose of the Study:
- To investigate the structural requirements for TRPM8 channel modulation.
- To identify novel TRPM8 activators and inhibitors using N-substituted tryptamines.
Main Methods:
- Synthesis of N-substituted tryptamines.
- Fluorescence-based screening assay to identify modulators.
- Patch-clamp electrophysiology to characterize compound activity.
- Molecular modeling studies to predict binding sites and modes.
Main Results:
- Compound 21 (2-(1H-indol-3-yl)-N-(4-phenoxybenzyl)ethanamine) acts as a TRPM8 activator with high potency.
- Compound 12 (N,N-dibenzyl-2-(1H-indol-3-yl)ethanamine) functions as a TRPM8 inhibitor.
- Molecular modeling revealed distinct binding modes for the agonist and antagonist within the TRPM8 channel.
Conclusions:
- N-substituted tryptamines represent a promising class of TRPM8 modulators.
- The identified compounds provide valuable tools for studying TRPM8 channel function.
- This research offers potential new avenues for treating pain and other diseases by targeting TRPM8.
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Thermosensation
Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Long-term Potentiation
Long-term Potentiation
Hebbian LTP
LTP can occur when...

